Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Nat Chem ; 15(6): 745-746, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37217788
2.
ACS Med Chem Lett ; 14(1): 18-25, 2023 Jan 12.
Article in English | MEDLINE | ID: mdl-36655130

ABSTRACT

GPR55 is an orphan G-protein coupled receptor involved in various pathophysiological conditions. However, there are only a few noncannabinoid GPR55 ligands reported so far. The lack of potent and selective GPR55 ligands precludes a deep exploration of this receptor. The studies presented here focused on a thienopyrimidine scaffold based on the GPR55 antagonist ML192, previously discovered by high-throughput screening. The GPR55 activities of the new synthesized compounds were assessed using ß-arrestin recruitment assays in Chinese hamster ovary cells overexpressing human GPR55. Some derivatives were identified as GPR55 antagonists with functional efficacy and selectivity versus CB1 and CB2 cannabinoid receptors.

3.
J Nat Prod ; 85(8): 2018-2025, 2022 08 26.
Article in English | MEDLINE | ID: mdl-35834411

ABSTRACT

Hypothemycin, an epoxide derivative of (5Z)-7-oxozeaenol, was used in the semisynthesis of a series of C8-C9 diol derivatives, with many inhibiting TAK1 at submicromolar concentrations. A step-economical approach was chosen, whereby nonselective reactions functionalized the diol to generate multiple analogues in a single reaction. Using this approach, 35 analogues were synthesized using 12 reactions, providing a wealth of information about the role that the C8-C9 diol plays in TAK1 inhibition and cytotoxicity in ovarian and breast cancer cell lines. Monofunctionalized analogues exhibited strong inhibition of TAK1, showing potential for modification of this section of the molecule to assist with solubility, formulation, and other desirable properties. Most analogues were cytotoxic, and three compounds had similar or slightly increased potency with >100-fold improvement in solubility profiles.


Subject(s)
Antineoplastic Agents , Antineoplastic Agents/pharmacology , Zearalenone/analogs & derivatives
4.
Org Biomol Chem ; 20(23): 4719-4723, 2022 Jun 15.
Article in English | MEDLINE | ID: mdl-35660842

ABSTRACT

Regioselective intermolecular mono- or bis-hydroalkoxylation of allenamides with alcohols using simple aluminum-catalyzed reaction conditions is reported. When the reaction was carried out with 1.1 equivalents of alcohol at 50 °C, N,O-acetals were generated by 1,2-addition of an alcohol. An increase in temperature to 80 °C leads to γ-substituted ethers by an intermolecular isomerization process. Treatment with an excess of alcohol (3 equiv.) at 50 °C gave 1,3-bis(alkoxy)propanamines. The reactions exhibited good functional group tolerance and efficiency, affording the products in moderate to good yields.

5.
J Antibiot (Tokyo) ; 74(8): 496-507, 2021 08.
Article in English | MEDLINE | ID: mdl-34155352

ABSTRACT

Resorcylic acid lactones (RALs) with a cis-enone moiety, represented by hypothemycin (1) and (5Z)-7-oxozeaenol (2), are fungal secondary metabolites with irreversible inhibitory activity against protein kinases, with particularly selective activity for inhibition of TAK1 (transforming growth factor beta-activated kinase 1). Gram-scale quantities of these compounds were needed as feedstock for semi-synthesizing RAL-analogues in a step-economical fashion. To do so, this study had three primary goals: identifying fungi that biosynthesized 1 and 2, enhancing their production by optimizing the fermentation conditions on the lab scale, and developing straight forward purification processes. After evaluating 536 fungal extracts via an in-house dereplication protocol, three strains were identified as producing cis-enone RALs (i.e., MSX78495, MSX63935, MSX45109). Screening these fungal strains on three grain-based media revealed enhanced production of 1 by strain MSX78495 on oatmeal medium, while rice medium increased the biosynthesis of 2 by strain MSX63935. Furthermore, the purification processes were improved, moving away from HPLC purification to utilizing two to four cycles of resuspension and centrifugation in small volumes of organic solvents, generating gram-scale quantities of these metabolites readily. In addition, studying the chemistry profiles of strains MSX78495 and MSX63935 resulted in the isolation of ten other RALs (3-12), two radicinin analogues (13-14), and six benzopyranones (15-20), with 19 and 20 being newly described chlorinated benzopyranones.


Subject(s)
Resorcinols/chemistry , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/isolation & purification , Chromatography, High Pressure Liquid , Culture Media , Fermentation , Fungi/metabolism , Lactones/chemistry , MAP Kinase Kinase Kinases/antagonists & inhibitors , Molecular Conformation , Protein Kinase Inhibitors/pharmacology , Resorcinols/pharmacology , Stereoisomerism , Structure-Activity Relationship , Zearalenone/analogs & derivatives , Zearalenone/biosynthesis , Zearalenone/isolation & purification
6.
Bioorg Med Chem ; 27(2): 338-342, 2019 01 15.
Article in English | MEDLINE | ID: mdl-30545734

ABSTRACT

Isocarbacyclin is a valuable synthetic analogue of prostacyclin with potential neuroprotective effects for the treatment of ischemic stroke. Herein, we describe the synthesis of isocarbacyclin and bicyclic analogues in only 7-10 steps, with the ω-side chain diversified at a late stage. A combination of new reaction design, function-oriented synthesis, and late-stage diversification led to a series of compounds that were tested for their neuroprotective activities. Efforts toward the synthesis of tricyclic analogues of isocarbacyclin, using the same combination of metal-catalyzed reactions, is also described.


Subject(s)
Bridged Bicyclo Compounds/pharmacology , Epoprostenol/analogs & derivatives , Neuroprotective Agents/pharmacology , Animals , Brain Ischemia/drug therapy , Bridged Bicyclo Compounds/chemical synthesis , Bridged Bicyclo Compounds/chemistry , Epoprostenol/chemical synthesis , Epoprostenol/chemistry , Epoprostenol/pharmacology , Mice , Neurons/drug effects , Neuroprotective Agents/chemical synthesis , Neuroprotective Agents/chemistry , Stereoisomerism , Stroke/drug therapy
7.
Org Lett ; 20(23): 7375-7379, 2018 12 07.
Article in English | MEDLINE | ID: mdl-30481039

ABSTRACT

Conditions for the first palladium-catalyzed chemoselective protodecarboxylation of polyenoic acids to give the desired polyenes in good yields are presented. The reactions proceed under mild conditions using either a Pd(0) or Pd(II) catalyst and tolerate a variety of aryl and aliphatic substitutions. Unique aspects of the reaction include the requirement of phosphines, water, and a polyene adjacent to the carboxylic acid.

8.
Org Lett ; 20(19): 6046-6050, 2018 10 05.
Article in English | MEDLINE | ID: mdl-30221526

ABSTRACT

A palladium(II) catalyst, in the presence of Selectfluor, enables the efficient and chemoselective transformation of primary amides into nitriles. The amides can be attached to aromatic rings, heteroaromatic rings, or aliphatic side chains, and the reactions tolerate steric bulk and electronic modification. Dehydration of a peptaibol containing three glutamine groups afforded structure-activity relationships for each glutamine residue. Thus, this dehydration can act similarly to an alanine scan for glutamines via synthetic mutation.


Subject(s)
Amides/chemistry , Nitriles/chemistry , Palladium/chemistry , Catalysis , Water/chemistry
9.
J Org Chem ; 82(22): 11772-11780, 2017 11 17.
Article in English | MEDLINE | ID: mdl-28841312

ABSTRACT

Phenylcyanocarbene was generated by the reaction of azide with a hypervalent iodonium alkynyl triflate and reacted in situ with 21 different carbocyclic and heterocyclic aromatic compounds. These reactions led to more complex products that frequently underwent subsequent rearrangements. The reactivity was further explored in a mechanistic study to ascertain the chemoselectivity and stereospecificity.

10.
Bioorg Med Chem ; 25(20): 5238-5246, 2017 10 15.
Article in English | MEDLINE | ID: mdl-28802670

ABSTRACT

Griseofulvin is a fungal metabolite and antifungal drug used for the treatment of dermatophytosis in both humans and animals. Recently, griseofulvin and its analogues have attracted renewed attention due to reports of their potential anticancer effects. In this study griseofulvin (1) and related analogues (2-6, with 4 being new to literature) were isolated from Xylaria cubensis. Six fluorinated analogues (7-12) were synthesized, each in a single step using the isolated natural products and Selectflour, so as to examine the effects of fluorine incorporation on the bioactivities of this structural class. The isolated and synthesized compounds were screened for activity against a panel of cancer cell lines (MDA-MB-435, MDA-MB-231, OVCAR3, and Huh7.5.1) and for antifungal activity against Microsporum gypseum. A comparison of the chemical space occupied by the natural and fluorinated analogues was carried out by using principal component analysis, documenting that the isolated and fluorinated analogues occupy complementary regions of chemical space. However, the most active compounds, including two fluorinated derivatives, were centered around the chemical space that was occupied by the parent compound, griseofulvin, suggesting that modifications must preserve certain attributes of griseofulvin to conserve its activity.


Subject(s)
Antifungal Agents/pharmacology , Antineoplastic Agents/pharmacology , Griseofulvin/pharmacology , Medical Informatics , Microsporum/drug effects , Xylariales/chemistry , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Griseofulvin/chemistry , Griseofulvin/isolation & purification , Halogenation , Humans , Microbial Sensitivity Tests , Molecular Structure , Principal Component Analysis , Structure-Activity Relationship , Tumor Cells, Cultured
11.
Bioorg Med Chem ; 25(16): 4355-4367, 2017 08 15.
Article in English | MEDLINE | ID: mdl-28673732

ABSTRACT

GPR55, a G protein-coupled receptor, is an attractive target to alleviate inflammatory and neuropathic pain and treat osteoporosis and cancer. Identifying a potent and selective ligand will aid to further establish the specific physiological roles and pharmacology of the receptor. Towards this goal, a targeted library of 22 compounds was synthesized in a modular fashion to obtain structure-activity relationship information. The general route consisted of coupling a variety of p-aminophenyl sulfonamides to isothiocyanates to form acylthioureas. For the synthesis of a known naphthyl ethyl alcohol motif, route modification led to a shorter and more efficient process. The 22 analogues were analyzed for their ability to serve as agonists at GPR55 and valuable information for both ends of the molecule was ascertained.


Subject(s)
Drug Design , Receptors, G-Protein-Coupled/agonists , Thiourea/pharmacology , Dose-Response Relationship, Drug , Humans , Molecular Structure , Receptors, Cannabinoid , Structure-Activity Relationship , Thiourea/analogs & derivatives , Thiourea/chemical synthesis
12.
Beilstein J Org Chem ; 13: 384-392, 2017.
Article in English | MEDLINE | ID: mdl-28382176

ABSTRACT

Dienoic acids and pentadienyl alcohols are coupled in a decarboxylative and dehydrative manner at ambient temperature using Pd(0) catalysis to generate 1,3,6,8-tetraenes. Contrary to related decarboxylative coupling reactions, an anion-stabilizing group is not required adjacent to the carboxyl group. Of mechanistic importance, it appears that both the diene of the acid and the diene of the alcohol are required for this reaction. To further understand this reaction, substitutions at every unique position of both coupling partners was examined and two potential mechanisms are presented.

13.
Bioorg Med Chem Lett ; 27(3): 612-615, 2017 02 01.
Article in English | MEDLINE | ID: mdl-27989666

ABSTRACT

The first structure-activity relationships for a benzothiazole scaffold acting as an antagonist at GPR35 is presented. Analogues were designed based on a lead compound that was previously determined to have selective activity as a GPR35 antagonist. The synthetic route was modular in nature to independently explore the role of the middle and both ends of the scaffold. The activities of the analogues illustrate the importance of all three segments of the compound.


Subject(s)
Benzothiazoles/chemistry , Receptors, G-Protein-Coupled/antagonists & inhibitors , Benzothiazoles/chemical synthesis , Benzothiazoles/metabolism , Cell Line, Tumor , Humans , Inhibitory Concentration 50 , Protein Binding , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Structure-Activity Relationship
14.
Bioorg Med Chem Lett ; 26(7): 1827-1830, 2016 Apr 01.
Article in English | MEDLINE | ID: mdl-26916440

ABSTRACT

A series of 1,3,4-oxadiazol-2-ones was synthesized and tested for activity as antagonists at GPR55 in cellular beta-arrestin redistribution assays. The synthesis was designed to be modular in nature so that a sufficient number of analogues could be rapidly accessed to explore initial structure-activity relationships. The design of analogues was guided by the docking of potential compounds into a model of the inactive form of GPR55. The results of the assays were used to learn more about the binding pocket of GPR55. With this oxadiazolone scaffold, it was determined that modification of the aryl group adjacent to the oxadiazolone ring was often detrimental and that the distal cyclopropane was beneficial for activity. These results will guide further exploration of this receptor.


Subject(s)
Drug Design , Oxadiazoles/chemistry , Oxadiazoles/pharmacology , Piperidines/chemistry , Piperidines/pharmacology , Receptors, G-Protein-Coupled/antagonists & inhibitors , Animals , Arrestins/metabolism , CHO Cells , Cricetulus , Humans , Molecular Docking Simulation , Oxadiazoles/chemical synthesis , Piperidines/chemical synthesis , Receptors, Cannabinoid , Receptors, G-Protein-Coupled/metabolism , Structure-Activity Relationship , beta-Arrestins
15.
Tetrahedron ; 71(47): 8899-904, 2015 Nov 25.
Article in English | MEDLINE | ID: mdl-26525642

ABSTRACT

Spiroscytalin (1), a new tetramic acid that possesses an uncommon spiro-ring fusion between a polyketide-derived octalin ring system and a 2,4-pyrrolidinedione, along with two known compounds, leporin B (2) and purpactin A (3), were isolated from a solid phase culture of the fungus Scytalidium cuboideum (MSX 68345). The molecular connectivity of 1-3 was determined using NMR spectroscopy and mass spectrometry. The relative configurations of 1 and 2 were determined by NOESY experiments. The absolute configuration of 1 was determined by electronic circular dichroism (ECD) via a combination of experimental measurements and computational calculations. While leporin B was known, it displayed activities that had not been reported previously, including cytotoxicity against three human tumor cell lines and antibacterial activity against Candida albicans and Staphylococcus aureus.

16.
Bioorg Med Chem ; 23(21): 6993-9, 2015 Nov 01.
Article in English | MEDLINE | ID: mdl-26481152

ABSTRACT

(5Z)-7-Oxozeanol and related analogues were isolated and screened to explore their activity as TAK1 inhibitors. Seven analogues were synthesized and more than a score of natural products isolated that examined the role that different areas of the molecule contribute to TAK1 inhibition. A novel nonaromatic difluoro-derivative was synthesized that had similar potency compared to the lead. This is the first example of a nonaromatic compound in this class to have TAK1 inhibition. Covalent docking for the isolated and synthesized analogues was carried out and found a strong correlation between the observed activities and the calculated binding.


Subject(s)
MAP Kinase Kinase Kinases/antagonists & inhibitors , Protein Kinase Inhibitors/chemical synthesis , Zearalenone/analogs & derivatives , Binding Sites , Humans , Inhibitory Concentration 50 , MAP Kinase Kinase Kinases/metabolism , Molecular Docking Simulation , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/metabolism , Protein Structure, Tertiary , Zearalenone/chemical synthesis , Zearalenone/chemistry , Zearalenone/metabolism
17.
Chem Commun (Camb) ; 51(25): 5287-9, 2015 Mar 28.
Article in English | MEDLINE | ID: mdl-25558484

ABSTRACT

The conversion of readily available silylalkynes, iodobenzene diacetate, and azide anions was utilized to form and react cyanocarbenes. A copper(II)-catalyzed reaction was found to react in a different manner. Both of these methods benefit from the formation and in situ reaction of hypervalent iodonium alkynyl triflates in O-H insertion reactions.

18.
Biochemistry ; 52(52): 9456-69, 2013 Dec 31.
Article in English | MEDLINE | ID: mdl-24274581

ABSTRACT

GPR55 is a class A G protein-coupled receptor (GPCR) that has been implicated in inflammatory pain, neuropathic pain, metabolic disorder, bone development, and cancer. Initially deorphanized as a cannabinoid receptor, GPR55 has been shown to be activated by non-cannabinoid ligands such as l-α-lysophosphatidylinositol (LPI). While there is a growing body of evidence of physiological and pathophysiological roles for GPR55, the paucity of specific antagonists has limited its study. In collaboration with the Molecular Libraries Probe Production Centers Network initiative, we identified a series of GPR55 antagonists using a ß-arrestin, high-throughput, high-content screen of ~300000 compounds. This screen yielded novel, GPR55 antagonist chemotypes with IC50 values in the range of 0.16-2.72 µM [Heynen-Genel, S., et al. (2010) Screening for Selective Ligands for GPR55: Antagonists (ML191, ML192, ML193) (Bookshelf ID NBK66153; PMID entry 22091481)]. Importantly, many of the GPR55 antagonists were completely selective, with no agonism or antagonism against GPR35, CB1, or CB2 up to 20 µM. Using a model of the GPR55 inactive state, we studied the binding of an antagonist series that emerged from this screen. These studies suggest that GPR55 antagonists possess a head region that occupies a horizontal binding pocket extending into the extracellular loop region, a central ligand portion that fits vertically in the receptor binding pocket and terminates with a pendant aromatic or heterocyclic ring that juts out. Both the region that extends extracellularly and the pendant ring are features associated with antagonism. Taken together, our results provide a set of design rules for the development of second-generation GPR55 selective antagonists.


Subject(s)
Drug Evaluation, Preclinical , Receptors, G-Protein-Coupled/antagonists & inhibitors , Receptors, G-Protein-Coupled/chemistry , Binding Sites , Humans , Inhibitory Concentration 50 , Ligands , Models, Molecular , Protein Binding , Receptors, Cannabinoid , Receptors, G-Protein-Coupled/metabolism
19.
J Vis Exp ; (79)2013 Sep 08.
Article in English | MEDLINE | ID: mdl-24056681

ABSTRACT

The procedures described in this article involve the synthesis and isolation of hypervalent iodonium alkynyl triflates (HIATs) and their subsequent reactions with azides to form cyanocarbene intermediates. The synthesis of hypervalent iodonium alkynyl triflates can be facile, but difficulties stem from their isolation and reactivity. In particular, the necessity to use filtration under inert atmosphere at -45 °C for some HIATs requires special care and equipment. Once isolated, the compounds can be stored and used in reactions with azides to form cyanocarbene intermediates. The evidence for cyanocarbene generation is shown by visible extrusion of dinitrogen as well as the characterization of products that occur from O-H insertion, sulfoxide complexation, and cyclopropanation. A side reaction of the cyanocarbene formation is the generation of a vinylidene-carbene and the conditions to control this process are discussed. There is also potential to form a hypervalent iodonium alkenyl triflate and the means of isolation and control of its generation are provided. The O-H insertion reaction involves using a HIAT, sodium azide or tetrabutylammonium azide, and methanol as solvent/substrate. The sulfoxide complexation reaction uses a HIAT, sodium azide or tetrabutylammonium azide, and dimethyl sulfoxide as solvent. The cyclopropanations can be performed with or without the use of solvent. The azide source must be tetrabutylammonium azide and the substrate shown is styrene.


Subject(s)
Alkynes/chemical synthesis , Mesylates/chemical synthesis , Methane/analogs & derivatives , Nitriles/chemical synthesis , Onium Compounds/chemical synthesis , Alkynes/chemistry , Azides/chemistry , Hydrocarbons, Iodinated/chemical synthesis , Hydrocarbons, Iodinated/chemistry , Mesylates/chemistry , Methane/chemical synthesis , Methane/chemistry , Nitriles/chemistry , Onium Compounds/chemistry
20.
J Org Chem ; 78(15): 7594-600, 2013 Aug 02.
Article in English | MEDLINE | ID: mdl-23876147

ABSTRACT

The mechanism for the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle is proposed to proceed by single-electron oxidation of coniferyl alcohol, subsequent reaction with one of the oxygen atoms of taxifolin's catechol moiety, and finally, further oxidation to form four of the major components of silymarin: silybin A, silybin B, isosilybin A, and isosilybin B. This mechanism is significantly different from a previously proposed process that involves the coupling of two independently formed radicals.


Subject(s)
Biomimetic Materials/chemical synthesis , Flavonolignans/chemical synthesis , Silybum marianum/chemistry , Biomimetic Materials/chemistry , Flavonolignans/chemistry , Molecular Structure , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...